A Novel Inflammatory and Nutritional Prognostic Scoring System for Nonpathological Complete Response Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy

Figure 4

Kaplan–Meier curves of different clinical T stage groups for OS and DFS. K-M analysis of OS (a) and DFS (b) for breast cancer patients by clinical T stage; K-M analysis of OS (c) and DFS (d) for breast cancer patients of T1 + T2 by INPS; K-M analysis of OS (e) and DFS (f) for breast cancer patietns of T3 + T4 by INPS.

(a)

(b)

(c)

(d)

(e)

(f)